Achieve Life Sciences, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Achieve Life Sciences, Inc. (ACHV) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 93.69 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 26.59M shares, a 17.21% increase year-over-year.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 22.68M shares, a 6.34% increase year-over-year.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 21.33M shares, a 193.18% increase year-over-year.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 7.28M shares, a 215.07% increase year-over-year.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 24.36T shares, a 15.50% increase from fiscal 2024.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 21.09T shares, a 198.74% increase from fiscal 2023.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.06T shares, a 110294946.88% increase from fiscal 2022.
- Achieve Life Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.40M shares, a 255.56% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 93.69M shares 10-Q · filed 2026-08-11 | |||||||
| 2026-03-31 | 26.59M shares 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | 24.36T shares 10-K · filed 2026-03-24 | |||||||
| 2025-09-30 | 37.30M shares 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | 39.00M shares 10-Q · filed 2026-08-11 | |||||||
| 2025-03-31 | 22.68M shares 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | 21.09T shares 10-K · filed 2025-03-11 | |||||||
| 2024-09-30 | 21.22M shares 10-Q · filed 2025-11-06 | |||||||
| 2024-06-30 | 21.22M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 21.33M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 7.06T shares 10-K · filed 2024-03-28 | |||||||
| 2023-09-30 | 7.09M shares 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | 7.09M shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 7.28M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 6.40M shares 10-K · filed 2023-03-16 | |||||||
| 2022-09-30 | 2.32M shares 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | 2.32M shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 2.31M shares 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | 1.80M shares 10-K · filed 2022-03-10 | |||||||
| 2021-09-30 | 1.82M shares 10-Q · filed 2021-11-09 | 1.82M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 1.78M shares 10-Q · filed 2021-08-12 | 1.78M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 1.78M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 1.50M shares 10-K · filed 2021-03-11 | |||||||
| 2020-09-30 | 1.40M shares 10-Q · filed 2021-11-09 | 1.40M shares 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | 1.63M shares 10-Q · filed 2021-08-12 | 1.63M shares 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | 1.48M shares 10-Q · filed 2021-05-13 | 29.62M shares 10-Q · filed 2020-05-14 | ||||||
| 2019-12-31 | 28.10M shares 10-K · filed 2020-03-13 | |||||||
| 2019-09-30 | 256.88K shares 10-Q · filed 2020-11-12 | 5.14M shares 10-Q · filed 2019-11-06 | 256.88K shares 10-Q · filed 2020-11-12 | 5.14M shares 10-Q · filed 2019-11-06 | ||||
| 2019-06-30 | 258.70K shares 10-Q · filed 2020-08-06 | 5.17M shares 10-Q · filed 2019-08-08 | 258.70K shares 10-Q · filed 2020-08-06 | 5.17M shares 10-Q · filed 2019-08-08 | ||||
| 2019-03-31 | 5.04M shares 10-Q · filed 2020-05-14 | 5.04M shares 10-Q · filed 2019-05-15 | ||||||
| 2018-12-31 | 4.70M shares 10-K · filed 2019-03-14 | |||||||
| 2018-09-30 | 3.85M shares 10-Q · filed 2019-11-06 | 3.85M shares 10-Q · filed 2019-11-06 | ||||||
| 2018-06-30 | 3.46M shares 10-Q · filed 2019-08-08 | 3.40M shares 10-Q · filed 2018-08-08 | 3.46M shares 10-Q · filed 2019-08-08 | 3.40M shares 10-Q · filed 2018-08-08 | ||||
| 2018-03-31 | 173.51K shares 10-Q · filed 2019-05-15 | 1.70M shares 10-Q · filed 2018-05-09 | ||||||
| 2017-12-31 | 1.70M shares 10-K · filed 2018-03-01 | |||||||
| 2017-09-30 | 174.41K shares 10-Q · filed 2018-11-07 | 1.70M shares 10-Q · filed 2017-11-09 | 174.41K shares 10-Q · filed 2018-11-07 | 1.70M shares 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | 4.90M shares 10-Q · filed 2017-07-31 | 0.00 shares 10-Q · filed 2018-08-08 | 4.90M shares 10-Q · filed 2017-07-31 | ||||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-09 | 5.20M shares 10-Q · filed 2017-05-15 | ||||||
| 2016-12-31 | 5.30M shares 10-K · filed 2017-02-23 | |||||||
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-09 | 7.00M shares 10-Q · filed 2016-11-10 | 0.00 shares 10-Q · filed 2017-11-09 | 7.00M shares 10-Q · filed 2016-11-10 | ||||
| 2016-06-30 | 7.10M shares 10-Q · filed 2017-07-31 | 7.10M shares 10-Q · filed 2017-07-31 | ||||||
| 2016-03-31 | 7.20M shares 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | 5.80M shares 10-K · filed 2017-02-23 | |||||||
| 2015-09-30 | 7.60M shares 10-Q · filed 2016-11-10 | 7.60M shares 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | 7.60M shares 10-Q · filed 2016-08-04 | 7.60M shares 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | 6.90M shares 10-Q · filed 2016-05-12 | |||||||
| 2014-12-31 | 7.00M shares 10-K · filed 2017-02-23 | |||||||
| 2014-09-30 | 8.30M shares 10-Q · filed 2014-10-30 | 8.30M shares 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | 3.70M shares 10-Q · filed 2015-08-13 | 3.70M shares 10-Q · filed 2015-08-13 | ||||||
| 2014-03-31 | 3.40M shares 10-Q · filed 2015-05-14 | |||||||
| 2013-12-31 | 3.00M shares 10-K · filed 2016-03-09 | |||||||
| 2013-09-30 | 2.90M shares 10-Q · filed 2014-10-30 | 2.90M shares 10-Q · filed 2014-10-30 | ||||||
| 2013-06-30 | 3.00M shares 10-Q · filed 2014-08-07 | 3.00M shares 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | 3.00M shares 10-Q · filed 2013-05-02 | |||||||
| 2012-12-31 | 2.60M shares 10-K · filed 2015-03-26 | |||||||
| 2011-12-31 | 2.40M shares 10-K · filed 2014-03-11 | |||||||
| 2010-12-31 | 2.30M shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |